This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hwang, R. F. Articles by Logsdon, C. D. Search for Related Content PubMed PubMed Citation Articles by Hwang, R. F. Articles by Logsdon, C. D.

Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression

Departments of ¹ Surgical Oncology and ² Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Rosa F. Hwang, Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 444, 1515 Holcombe Boulevard, Houston, TX 77230-1402. Phone: 713-563-1873; Fax: 713-745-1462; E-mail: rhwang{at}mdanderson.org.

Key Words: pancreatic cancer • stroma • microenvironment • fibroblasts • xenograft

Pancreatic adenocarcinoma is characterized by a dense background of tumor associated stroma originating from abundant pancreatic stellate cells. The aim of this study was to determine the effect of human pancreatic stellate cells (HPSC) on pancreatic tumor progression. HPSCs were isolated from resected pancreatic adenocarcinoma samples and immortalized with telomerase and SV40 large T antigen. Effects of HPSC conditioned medium (HPSC-CM) on in vitro proliferation, migration, invasion, soft-agar colony formation, and survival in the presence of gemcitabine or radiation therapy were measured in two pancreatic cancer cell lines. The effects of HPSCs on tumors were examined in an orthotopic murine model of pancreatic cancer by co-injecting them with cancer cells and analyzing growth and metastasis. HPSC-CM dose-dependently increased BxPC3 and Panc1 tumor cell proliferation, migration, invasion, and colony formation. Furthermore, gemcitabine and radiation therapy were less effective in tumor cells treated with HPSC-CM. HPSC-CM activated the mitogen-activated protein kinase and Akt pathways in tumor cells. Co-injection of tumor cells with HPSCs in an orthotopic model resulted in increased primary tumor incidence, size, and metastasis, which corresponded with the proportion of HPSCs. HPSCs produce soluble factors that stimulate signaling pathways related to proliferation and survival of pancreatic cancer cells, and the presence of HPSCs in tumors increases the growth and metastasis of these cells. These data indicate that stellate cells have an important role in supporting and promoting pancreatic cancer. Identification of HPSC-derived factors may lead to novel stroma-targeted therapies for pancreatic cancer. [Cancer Res 2008;68(3):918–26]

This article has been cited by other articles:

				P. A. Philip, M. Mooney, D. Jaffe, G. Eckhardt, M. Moore, N. Meropol, L. Emens, E. O'Reilly, M. Korc, L. Ellis, et al. Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment J. Clin. Oncol., November 20, 2009; 27(33): 5660 - 5669. [Abstract] [Full Text] [PDF]

				Y. Lu, W. Yang, C. Qin, L. Zhang, J. Deng, S. Liu, and Z. Qin Responsiveness of Stromal Fibroblasts to IFN-{gamma} Blocks Tumor Growth via Angiostasis J. Immunol., November 15, 2009; 183(10): 6413 - 6421. [Abstract] [Full Text] [PDF]

				S. A. Blaine, K. C. Ray, K. M. Branch, P. S. Robinson, R. H. Whitehead, and A. L. Means Epidermal growth factor receptor regulates pancreatic fibrosis Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G434 - G441. [Abstract] [Full Text] [PDF]

				F. E.M. Froeling, T. A. Mirza, R. M. Feakins, A. Seedhar, G. Elia, I. R. Hart, and H. M. Kocher Organotypic Culture Model of Pancreatic Cancer Demonstrates that Stromal Cells Modulate E-Cadherin, {beta}-Catenin, and Ezrin Expression in Tumor Cells Am. J. Pathol., August 1, 2009; 175(2): 636 - 648. [Abstract] [Full Text] [PDF]

				T. Arumugam, V. Ramachandran, K. F. Fournier, H. Wang, L. Marquis, J. L. Abbruzzese, G. E. Gallick, C. D. Logsdon, D. J. McConkey, and W. Choi Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer Cancer Res., July 15, 2009; 69(14): 5820 - 5828. [Abstract] [Full Text] [PDF]

				A Masamune, K Kikuta, T Watanabe, K Satoh, M Hirota, S Hamada, and T Shimosegawa Fibrinogen induces cytokine and collagen production in pancreatic stellate cells Gut, April 1, 2009; 58(4): 550 - 559. [Abstract] [Full Text] [PDF]

				J. W. Gallagher, N. Kubica, S. R. Kimball, and L. S. Jefferson Reduced Eukaryotic Initiation Factor 2B{varepsilon}-Subunit Expression Suppresses the Transformed Phenotype of Cells Overexpressing the Protein Cancer Res., November 1, 2008; 68(21): 8752 - 8760. [Abstract] [Full Text] [PDF]

				A. Vonlaufen, P. A. Phillips, Z. Xu, D. Goldstein, R. C. Pirola, J. S. Wilson, and M. V. Apte Pancreatic Stellate Cells and Pancreatic Cancer Cells: An Unholy Alliance Cancer Res., October 1, 2008; 68(19): 7707 - 7710. [Abstract] [Full Text] [PDF]

				M Mimeault and S K Batra Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer Gut, October 1, 2008; 57(10): 1456 - 1468. [Abstract] [Full Text] [PDF]

				D. M. Simeone Pancreatic Cancer Stem Cells: Implications for the Treatment of Pancreatic Cancer Clin. Cancer Res., September 15, 2008; 14(18): 5646 - 5648. [Abstract] [Full Text] [PDF]